Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Multifocal theta-burst stimulation to boost arm recovery after stroke

Official title: Advancing Stroke Rehabilitation Through Multifocal Network-based Theta-burst Stimulation and Assistive Technology: Enhancing Upper Limb Motor Learning: A Single-center, Randomized, Sham-controlled Study With Parallel Groups.

Run by School of Health Sciences Geneva · NCT07439367 · Data updated 2026-11-12

This trial tests whether sequential intermittent theta-burst brain stimulation to motor and parietal areas, combined with tablet-based arm training, can improve arm movement in adults with chronic stroke-related weakness.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment46 (estimated)
SponsorSchool of Health Sciences Geneva
Academic / other
Locations1 site (Carouge, Canton of Geneva)
StatusRecruiting
StartedSeptember 5, 2025
Main results expectedAugust 31, 2026
Study endsAugust 31, 2026
Registry record updatedFebruary 27, 2026
Trial IDNCT07439367 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older who are at least six months after a first ischemic or hemorrhagic stroke, have unilateral upper-limb weakness with FMA-UE scores of 29–57, and can follow study procedures.

Probably not a fit

Patients with severe paralysis (FMA-UE below 29), uncontrolled epilepsy, recent botulinum toxin injections, implanted metallic or electronic devices near the stimulation site, or who experience a recurrent stroke are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study delivers neuronavigated intermittent theta-burst stimulation (iTBS) sequentially to the affected hemisphere's primary motor cortex and superior parietal lobule, paired with tablet-based upper limb exercises, and compares active stimulation to sham. Eligible participants are adults at least six months after a first unilateral ischemic or hemorrhagic stroke with moderate residual arm weakness (FMA-UE 29–57). The intervention aims to enhance parietal–motor network functional connectivity to promote neuroplasticity and motor relearning. Outcomes focus on changes in upper-limb function following the combined neuromodulation and training program.

Why it matters

Potential benefit: If successful, this approach could strengthen brain network connectivity to improve arm strength and day-to-day use for people living with chronic post-stroke weakness.

How similar studies have gone: Previous rTMS and monofocal iTBS trials over motor cortex have shown mixed but promising effects on chronic stroke motor recovery, while multifocal parietal-plus-motor iTBS is a relatively new and less-tested strategy.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For Stroke Participants:

* Age ≥ 18 years
* First-ever ischemic or hemorrhagic stroke
* Time since stroke ≥ 6 months
* Unilateral upper limb hemiparesis
* Fugl-Meyer Assessment Upper Extremity (FMA-UE) score between 29 and 57
* Modified Ashworth Scale score \< 2 at elbow, wrist, or finger flexors
* Manual muscle testing ≥ 3/5 in proximal upper limb muscles (deltoid, biceps, triceps, wrist pronators/supinators)
* Ability to understand and follow study procedures
* Provided written informed consent

For Healthy Participants:

* Age ≥ 18 years
* No history of neurological disease
* Ability to understand and follow study procedures
* Provided written informed consent

Exclusion Criteria:

For Stroke Participants:

* Second stroke occurring during the study period
* Botulinum toxin injection within 3 months prior to study start
* History of one or more epileptic seizures
* Metallic object near the stimulation site
* Implanted electronic or metallic devices (e.g., pacemaker, neurostimulator) incompatible with TMS
* Severe comorbid conditions affecting the upper limb (traumatic, rheumatologic, osteoarticular, or neurodegenerative disorders)
* Pregnancy
* Delirium or impaired vigilance
* Inability to participate in one-hour treatment sessions
* Inability to comply with study procedures (e.g., language barrier, psychological disorder, dementia)
* Current or past substance abuse, including excessive alcohol consumption
* Participation in another interventional clinical trial within 30 days prior to enrollment

For Healthy Participants:

* Severe musculoskeletal or neurological condition affecting the non-dominant upper limb
* Pregnancy
* Delirium or impaired vigilance
* Inability to participate in one-hour treatment sessions
* Inability to comply with study procedures
* Current or past substance abuse, including excessive alcohol consumption
* Participation in another interventional clinical trial within 30 days prior to enrollment

Where it's running

  • University School of Health ▪ HES-SO Genève
    Carouge, Canton of Geneva, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.